Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Autolus Therapeutics (AUTL) Tax Provisions: 2016-2024

Historic Tax Provisions for Autolus Therapeutics (AUTL) over the last 9 years, with Dec 2024 value amounting to $1.5 million.

  • Autolus Therapeutics' Tax Provisions rose 2318.18% to $532,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year increase of 11158.54%. This contributed to the annual value of $1.5 million for FY2024, which is 8142.11% up from last year.
  • Per Autolus Therapeutics' latest filing, its Tax Provisions stood at $1.5 million for FY2024, which was up 8,142.11% from -$19,000 recorded in FY2023.
  • Autolus Therapeutics' Tax Provisions' 5-year high stood at $1.5 million during FY2024, with a 5-year trough of -$24.2 million in FY2020.
  • In the last 3 years, Autolus Therapeutics' Tax Provisions had a median value of $300,000 in 2022 and averaged $603,000.
  • Its Tax Provisions has fluctuated over the past 5 years, first plummeted by 106.33% in 2023, then surged by 8,142.11% in 2024.
  • Over the past 5 years, Autolus Therapeutics' Tax Provisions (Yearly) stood at -$24.2 million in 2020, then surged by 100.41% to $100,000 in 2021, then skyrocketed by 200.00% to $300,000 in 2022, then plummeted by 106.33% to -$19,000 in 2023, then skyrocketed by 8,142.11% to $1.5 million in 2024.